Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles

Neofytos, 2010, Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients, Transpl. Infect. Dis., 12, 220, 10.1111/j.1399-3062.2010.00492.x Nampoory, 1996, Invasive fungal infections in renal transplant recipients, J. Infect., 33, 95, 10.1016/S0163-4453(96)92986-2 Pappas, 2010, Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET), Clin. Infect. Dis., 50, 1101, 10.1086/651262 Matignon, 2008, Outcome of renal transplantation in eight patients with Candida spp. contamination of preservation fluid, Am. J. Transplant., 8, 697, 10.1111/j.1600-6143.2007.02112.x Kritikos, 2016, Bloodstream infections after solid-organ transplantation, Virulence, 7, 329, 10.1080/21505594.2016.1139279 Pfaller, 2007, Epidemiology of invasive candidiasis: a persistent public health problem, Clin. Microbiol. Rev., 20, 133, 10.1128/CMR.00029-06 Perlroth, 2007, Nosocomial fungal infections: epidemiology, diagnosis, and treatment, Med. Mycol., 45, 321, 10.1080/13693780701218689 Vaezi, 2017, Epidemiological and mycological characteristics of candidemia in Iran: a systematic review and meta-analysis, J. Mycol. Med., 27, 146, 10.1016/j.mycmed.2017.02.007 Beyda, 2012, Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches, Ann. Pharmacother., 46, 1086, 10.1345/aph.1R020 Gonçalves, 2016, Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus, Mycoses, 59, 198, 10.1111/myc.12469 Tadec, 2016, Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7‐year study, Mycoses, 59, 296, 10.1111/myc.12470 Bouza, 2008, Epidemiology of candidemia in intensive care units, Int. J. Antimicrob. Agents, 32, S87, 10.1016/S0924-8579(08)70006-2 Cornely, 2012, ESCMID guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients, Clin. Microbiol. Infect., 18, 19, 10.1111/1469-0691.12039 Ullmann, 2012, ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT), Clin. Microbiol. Infect., 18, 53, 10.1111/1469-0691.12041 Chandrasekar, 2010, Management of invasive fungal infections: a role for polyenes, J. Antimicrob. Chemother., 66, 457, 10.1093/jac/dkq479 Rüping, 2008, Antifungal treatment strategies in high risk patients, Mycoses, 51, 46, 10.1111/j.1439-0507.2008.01572.x Singh, 2000, Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy, Clin. Infect. Dis., 31, 545, 10.1086/313943 Alexander, 2008, Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant, Transplantation, 86, 791, 10.1097/TP.0b013e3181837585 Fakhim, 2016, In vitro activities of novel azole compounds (ATTAF-1 and ATTAF-2) against fluconazole-susceptible and-resistant isolates of Candida species, Antimicrob. Agents Chemother., 27, 61 Nyilasi, 2010, Effect of different statins on the antifungal activity of polyene antimycotics, Acta Biol. Szeged., 54, 33 Zhou, 2018, Lovastatin synergizes with itraconazole against planktonic cells and biofilms of Candida albicans through the regulation on ergosterol biosynthesis pathway, Appl. Microbiol. Biotechnol., 102, 5255, 10.1007/s00253-018-8959-8 Pappas, 2006, Invasive fungal infections in low‐risk liver transplant recipients: a multi‐center prospective observational study, Am. J. Transplant., 6, 386, 10.1111/j.1600-6143.2005.01176.x Altiparmak, 2002, Systemic fungal infections after renal transplantation, Scand. J. Infect. Dis., 34, 284, 10.1080/00365540110077470 De Pauw, 2008, Clin. Infect. Dis., 15, 1813, 10.1086/588660 Mirhendi, 2006, A one-enzyme PCR-RFLP assay for identification of six medically important Candida species, Nippon Ishinkin Gakkai Zasshi, 47, 225, 10.3314/jjmm.47.225 Mohammadi, 2013, Molecular identification and distribution profile of Candida species isolated from Iranian patients, Med. Mycol., 51, 657, 10.3109/13693786.2013.770603 Clinical and Laboratory Standards Institute, 2008 Pfaller, 2012, Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012, J. Clin. Microbiol., 50, 2846, 10.1128/JCM.00937-12 Espinel-Ingroff, 2016, The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds, Rev. Iberoam. De. Micol., 33, 63, 10.1016/j.riam.2016.04.001 Espinel-Ingroff, 2014, Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole, Antimicrob. Agents Chemother., 58, 2006, 10.1128/AAC.02615-13 Gallis, 1975, Fungal infection following renal transplantation, Arch. Intern. Med., 135, 1163, 10.1001/archinte.1975.00330090035004 Peterson, 1982, Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem, Medicine, 61, 360, 10.1097/00005792-198211000-00002 Einollahi, 2008, Invasive fungal infections following renal transplantation: a review of 2410 recipients, Ann. Transplant., 13, 55 Dongari-Bagtzoglou, 2009, Oral Candida infection and colonization in solid organ transplant recipients, Oral Microbiol. Immunol., 24, 249, 10.1111/j.1399-302X.2009.00505.x Bassetti, 2011, Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy, PLoS One, 6, e24198, 10.1371/journal.pone.0024198 Pfaller, 2014, Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004–2008, PLoS One, 9, e101510, 10.1371/journal.pone.0101510 Li, 2007, Candida glabrata, an emerging oral opportunistic pathogen, J. Dent. Res., 86, 204, 10.1177/154405910708600304 Rezai, 2017, Successful treatment with caspofungin of candiduria in a child with Wilms tumor; review of literature, J. Mycol. Med., 27, 261, 10.1016/j.mycmed.2017.01.006 Doi, 2016, Epidemiology and microbiologic characterization of nosocomial candidemia from a Brazilian national surveillance program, PLoS One, 11, e0146909, 10.1371/journal.pone.0146909 Clark, 2004, Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital, J. Clin. Microbiol., 42, 4468, 10.1128/JCM.42.10.4468-4472.2004 Taj-Aldeen, 2014, Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern, Infection, 42, 393, 10.1007/s15010-013-0570-4 Caggiano, 2015, Candida bloodstream infections in Italy: changing epidemiology during 16 years of surveillance, BioMed Res. Int., 2015, 256580, 10.1155/2015/256580 Pfaller, 2003, In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates, Antimicrob. Agents Chemother., 47, 1068, 10.1128/AAC.47.3.1068-1071.2003 Beyda, 2012, Treatment of Candida famata bloodstream infections: case series and review of the literature, J. Antimicrob. Chemother., 68, 438, 10.1093/jac/dks388 Sanchis, 2016, Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection, Diagn. Microbiol. Infect. Dis., 84, 48, 10.1016/j.diagmicrobio.2015.09.010 Dufresne, 2014, Epidemiology of Candida kefyr in patients with hematologic malignancies, J. Clin. Microbiol., 52, 1830, 10.1128/JCM.00131-14 Mane, 2016, Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India, Mycoses, 59, 93, 10.1111/myc.12439 Pfaller, 2008, In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance, J. Clin. Microbiol., 46, 150, 10.1128/JCM.01901-07 Prigent, 2017, Echinocandin resistance in Candida species isolates from liver transplant recipients, Antimicrob. Agents Chemother., 61, 10.1128/AAC.01229-16 Arendrup, 2014, ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections, Clin. Microbiol. Infect., 20, 76, 10.1111/1469-0691.12360 Pfaller, 2013, J. Clin. Microbiol., 51, 2571, 10.1128/JCM.00308-13